rewire.itbenchmarks
Task

NABench CCV-CORR-RIBOZYME: Fitness prediction on ribozyme assays, supervised, contiguous cross validation

Fitness prediction on ribozyme assays, supervised, contiguous cross validation. Scored with Spearman ρ on NABench ribozyme assays. Scored supervised, contiguous cross validation across the NABench ribozyme assays.

25 evaluations · 25 results

Overview

Fitness prediction on ribozyme assays, supervised, contiguous cross validation. Scored with Spearman ρ on NABench ribozyme assays. Scored supervised, contiguous cross validation across the NABench ribozyme assays.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Results

Each comparison retains its reviewed evaluation scope, dataset and metric. Results are shown without a pooled ranking.

NABench CCV-CORR-RIBOZYME: Fitness prediction on ribozyme assays, supervised, contiguous cross validation

spearman (correlation) · Higher values are better.

NABench CCV-CORR-RIBOZYME: Fitness prediction on ribozyme assays, supervised, contiguous cross validation · NABench ribozyme assays (NABench split)

Evidence origin: Author-reported evaluation.

NABench: Large-Scale Benchmarks of Nucleotide Foundation Models for Fitness Prediction · Table 11, column(ribozyme)
  • Zero-shot, few-shot and supervised cross validation figures come from different protocols and are not comparable to each other.
  • The per-nucleotide-type figures and the overall figures describe the same runs at different resolutions, so they must not be combined.
Comparison details and limitations

Every method NABench reports on Fitness prediction on ribozyme assays, supervised, contiguous cross validation, scored with Spearman ρ on NABench ribozyme assays.

  • Author-reported numbers, source checked but not independently reproduced.

Automated source review: 2026-09-18. Numerical source review does not establish independent reproduction.

Dots show point estimates. Whiskers show only explicitly defined uncertainty (standard deviation, standard error or a labelled interval); their definitions remain in Table. Unresolved uncertainty is not plotted. Differences do not establish statistical significance.

Showing 12 of 25 matching rows.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Evaluation design

Benchmarks bring together tasks and protocols. A task describes the biological question; a protocol defines a particular test.

Benchmarks

These source-backed links do not make different protocols or scores interchangeable.

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Explore all linked results

Run instructions

No runnable recipe has been reviewed for this task. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

A task describes a biological question. Choose a linked protocol to obtain concrete split and scoring instructions.

Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-09-29-06401fd5b220
Property and statementOriginal source and locationReview and provenance
Relationship: part of
discovery-benchmark-nabench
Individual claims
NABench: Large-Scale Benchmarks of Nucleotide Foundation Models for Fitness Prediction

Original source ↗

Table 11, column(ribozyme)

Version: Primary full-text snapshot retrieved 2026-09-17; exact bytes pinned by SHA-256
Retrieved: 2026-09-17T08:06:28.183421+00:00

source checked

automated source review · 2026-09-18

Audit details

Primary-source transcription with no human sign-off and no independent reproduction.

Field: links:part_of:discovery-benchmark-nabench

Claim: nabench-association-ccv-corr-ribozyme

Source artifact SHA-256: fefd48d53b1a7eadf9e14db96adacc8e646304c1b592562d9f136f4508941350

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

Sources and history

View linked audit checks and correction history

Release 2026-09-29-06401fd5b220 · Record review: source checked

1 source records and release historyDownload this release
Technical metadata and extraction receipts

Stable ID: nabench-task-ccv-corr-ribozyme

areas
rna-transcriptomes
tasks
Fitness prediction on ribozyme assays, supervised, contiguous cross validation
metric
Spearman ρ
metric direction
higher
dataset
NABench ribozyme assays
protocol
Scored supervised, contiguous cross validation across the NABench ribozyme assays.
source locator
Table 11, column(ribozyme)
comparison panels
id: nabench-panel-ccv-corr-ribozyme; title: NABench CCV-CORR-RIBOZYME: Fitness prediction on ribozyme assays, supervised, contiguous cross validation; protocol id: nabench-task-ccv-corr-ribozyme; dataset id: nabench-dataset-nabench-ribozyme-assays; metric: spearman; unit: correlation; direction: higher; result ids: nabench-result-rna-fm-ccv-corr-ribozyme-spearman; nabench-result-lucaone-ccv-corr-ribozyme-spearman; nabench-result-resm-ccv-corr-ribozyme-spearman; nabench-result-enformer-ccv-corr-ribozyme-spearman; nabench-result-generator-3b-ccv-corr-ribozyme-spearman; nabench-result-structrfm-ccv-corr-ribozyme-spearman; nabench-result-space-ccv-corr-ribozyme-spearman; nabench-result-n-t-v2-50m-ccv-corr-ribozyme-spearman; nabench-result-evo-1-5-8k-base-ccv-corr-ribozyme-spearman; nabench-result-evo2-7b-ccv-corr-ribozyme-spearman; nabench-result-crafts-ccv-corr-ribozyme-spearman; nabench-result-evo-1-8k-base-ccv-corr-ribozyme-spearman; nabench-result-evo-1-8k-ccv-corr-ribozyme-spearman; nabench-result-birna-bert-ccv-corr-ribozyme-spearman; nabench-result-rnaernie-ccv-corr-ribozyme-spearman; nabench-result-evo2-7b-base-ccv-corr-ribozyme-spearman; nabench-result-gena-lm-large-ccv-corr-ribozyme-spearman; nabench-result-hyenadna-ccv-corr-ribozyme-spearman; nabench-result-rinalmo-giga-ccv-corr-ribozyme-spearman; nabench-result-generrna-ccv-corr-ribozyme-spearman; nabench-result-dnabert-ccv-corr-ribozyme-spearman; nabench-result-aido-rna-ccv-corr-ribozyme-spearman; nabench-result-lucavirus-ccv-corr-ribozyme-spearman; nabench-result-genslm-ccv-corr-ribozyme-spearman; nabench-result-dnabert-6-ccv-corr-ribozyme-spearman; source ids: evidence-expansion-nabench-fefd48d5; source locator: Table 11, column(ribozyme); context: Every method NABench reports on Fitness prediction on ribozyme assays, supervised, contiguous cross validation, scored with Spearman ρ on NABench ribozyme assays.; caveats: Author-reported numbers, source checked but not independently reproduced.; Zero-shot, few-shot and supervised cross validation figures come from different protocols and are not comparable to each other.; The per-nucleotide-type figures and the overall figures describe the same runs at different resolutions, so they must not be combined.; review: method: automated_source_review; date: 2026-09-18
Related records

Suggest a correction